Genus plc (LON:GNS – Get Free Report) insider Jorgen Kokke sold 50,236 shares of the stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of GBX 2,151, for a total transaction of £1,080,576.36.
Genus Price Performance
Shares of LON GNS opened at GBX 2,115.29 on Friday. The stock’s 50-day simple moving average is GBX 2,226.85 and its 200-day simple moving average is GBX 2,341.14. The firm has a market capitalization of £1.40 billion, a PE ratio of 29.79, a price-to-earnings-growth ratio of 2.87 and a beta of 0.90. Genus plc has a fifty-two week low of GBX 1,943 and a fifty-two week high of GBX 3,220. The company has a debt-to-equity ratio of 14.02, a quick ratio of 1.08 and a current ratio of 2.22.
Genus (LON:GNS – Get Free Report) last announced its quarterly earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share (EPS) for the quarter. Genus had a return on equity of 44.90% and a net margin of 43.35%. As a group, equities research analysts forecast that Genus plc will post 70.9644323 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on GNS
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
- Five stocks we like better than Genus
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
